Page last updated: 2024-10-30

mecamylamine and Apoplexy

mecamylamine has been researched along with Apoplexy in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Oliveira, RC1
de Oliveira, R1
Biagioni, AF1
Falconi-Sobrinho, LL1
Coimbra, NC1
Ofek, K1
Schoknecht, K1
Melamed-Book, N1
Heinemann, U1
Friedman, A1
Soreq, H1

Other Studies

2 other studies available for mecamylamine and Apoplexy

ArticleYear
Dorsal raphe nucleus acetylcholine-mediated neurotransmission modulates post-ictal antinociception: The role of muscarinic and nicotinic cholinergic receptors.
    Brain research, 2016, Jan-15, Volume: 1631

    Topics: Acetylcholine; Analgesics; Animals; Atropine; Dorsal Raphe Nucleus; Epilepsy, Tonic-Clonic; GABAergi

2016
Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:11

    Topics: Acetylcholinesterase; Animals; Arterioles; Atropine; Calcium; Cells, Cultured; Cerebral Cortex; Dise

2012